Oklahoma C. difficile U19 Challenge Core
俄克拉荷马州艰难梭菌 U19 挑战核心
基本信息
- 批准号:10625174
- 负责人:
- 金额:$ 7.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-25 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:Animal ModelAntibiotic TherapyAntibioticsClostridium difficileDataDedicationsDiseaseDoseEnsureEnvironmentGenerationsGoalsHamstersHealthIndividualInfectionJointsLaboratoriesMeasuresMethodsModalityModelingMonitorMusOklahomaOralOutcomePredispositionProceduresPublic HealthPublicationsReagentRecurrenceRecurrent diseaseReproducibilityReproduction sporesResearchResearch PersonnelResearch Project GrantsServicesStandardizationVaccinatedVaccinationVaccinesVariantWithdrawalefficacy testingexperienceexperimental studygut microbiomeinterestmicrobiomemouse modelpathogenprogramsrecurrent infectionvaccine candidatevaccine efficacyvaccine evaluationvaccine response
项目摘要
Project Summary (Challenge Core)
The central goal of the Oklahoma C. difficile U19 program is to advance a second-generation vaccine for C.
difficile by revealing mechanisms that limit protective vaccine-induced responses. In order to achieve these
goals, challenge experiments are required whereby relevant animal models are used to test vaccine efficacy.
Given that the U19 program has 3 distinct but complementary Research Projects and that synergistic interaction
between those projects is desirable, standardization of the challenge experiments is a prudent and essential
measure. Towards, this goal, we will build upon our experience with murine and hamster challenge models to
develop a coordinated ‘Challenge Core’ which will provide a standardized service to each of the Research
Projects. In Specific Aim 1, a single infection murine challenge model will be further developed as a core service.
In Specific Aim 2, a repeat infection model will be further optimized and provided as a core service. In Specific
Aim 3, a hamster challenge model will be established and provided as a core service for promising vaccination
modalities. Importantly, all approaches are utilized currently by the Ballard and/or Lang laboratories, but will be
further developed to ensure standardization and experimental rigor with regard to environment, microbiome,
reagents, methods, and readouts. A dedicated core will also relieve the burden on individual projects and
facilitate rigorous experimentation. The core service will be made available to other investigators interested in C.
difficile research and will lower the barrier to setting up challenge experiments for specific projects.
项目总结(挑战核心)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jimmy D. Ballard其他文献
A toxin contest
一场毒素竞赛
- DOI:
10.1038/467665a - 发表时间:
2010-10-06 - 期刊:
- 影响因子:48.500
- 作者:
Jimmy D. Ballard - 通讯作者:
Jimmy D. Ballard
CSPG4-dependent cytotoxicity for emC. difficile/em TcdB is influenced by extracellular calcium and chondroitin sulfate
艰难梭菌 TcdB 对 emC 的 CSPG4 依赖性细胞毒性受细胞外钙和硫酸软骨素的影响
- DOI:
10.1128/msphere.00094-24 - 发表时间:
2024-03-12 - 期刊:
- 影响因子:3.100
- 作者:
D. Annie Doyle;Paul L. DeAngelis;Jimmy D. Ballard;Sarah E. F. D'Orazio - 通讯作者:
Sarah E. F. D'Orazio
Critical intermediate steps in <em>Clostridium sordellii</em> lethal toxin-induced apoptosis
- DOI:
10.1016/j.bbrc.2007.09.073 - 发表时间:
2007-11-30 - 期刊:
- 影响因子:
- 作者:
Daniel E. Voth;Jimmy D. Ballard - 通讯作者:
Jimmy D. Ballard
A toxin contest
一场毒素竞赛
- DOI:
10.1038/467665a - 发表时间:
2010-10-06 - 期刊:
- 影响因子:48.500
- 作者:
Jimmy D. Ballard - 通讯作者:
Jimmy D. Ballard
Jimmy D. Ballard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jimmy D. Ballard', 18)}}的其他基金
Enhancing C. difficile vaccination in the context of TcdB-mediated immunosuppression.
在 TcdB 介导的免疫抑制背景下加强艰难梭菌疫苗接种。
- 批准号:
10625175 - 财政年份:2023
- 资助金额:
$ 7.32万 - 项目类别:
Oklahoma Center for Microbial Pathogenesis and Immunity
俄克拉荷马州微生物发病机制和免疫中心
- 批准号:
10341201 - 财政年份:2020
- 资助金额:
$ 7.32万 - 项目类别:
Oklahoma Center for Microbial Pathogenesis and Immunity
俄克拉荷马州微生物发病机制和免疫中心
- 批准号:
10554351 - 财政年份:2020
- 资助金额:
$ 7.32万 - 项目类别:
Differential Effects of TcdB1 and TcdB2 in C. difficile disease
TcdB1 和 TcdB2 在艰难梭菌疾病中的不同作用
- 批准号:
10094178 - 财政年份:2015
- 资助金额:
$ 7.32万 - 项目类别:
Differential Effects of TcdB1 and TcdB2 in C. difficile disease
TcdB1 和 TcdB2 在艰难梭菌疾病中的不同作用
- 批准号:
8945312 - 财政年份:2015
- 资助金额:
$ 7.32万 - 项目类别:
Differential Effects of TcdB1 and TcdB2 in C. difficile disease
TcdB1 和 TcdB2 在艰难梭菌疾病中的不同作用
- 批准号:
10331732 - 财政年份:2015
- 资助金额:
$ 7.32万 - 项目类别:
Differential Effects of TcdB1 and TcdB2 in C. difficile disease
TcdB1 和 TcdB2 在艰难梭菌疾病中的不同作用
- 批准号:
10548849 - 财政年份:2015
- 资助金额:
$ 7.32万 - 项目类别:
Edema Toxin Suppression of Immune Responses During Anthrax Disease
炭疽病期间水肿毒素抑制免疫反应
- 批准号:
7695606 - 财政年份:2009
- 资助金额:
$ 7.32万 - 项目类别:
相似海外基金
SBIR Phase II: Development of a urine dipstick test that can guide immediate and appropriate antibiotic therapy for treatment of complicated urinary tract infections
SBIR II 期:开发尿液试纸测试,可以指导复杂尿路感染的立即和适当的抗生素治疗
- 批准号:
2213034 - 财政年份:2023
- 资助金额:
$ 7.32万 - 项目类别:
Cooperative Agreement
Personalized Antibiotic Therapy in the Emergency Department: PANTHER Trial
急诊科的个性化抗生素治疗:PANTHER 试验
- 批准号:
10645528 - 财政年份:2023
- 资助金额:
$ 7.32万 - 项目类别:
Strategies for improving the efficacy of combinatorial antibiotic therapy in chronic infections
提高慢性感染联合抗生素治疗疗效的策略
- 批准号:
10736285 - 财政年份:2023
- 资助金额:
$ 7.32万 - 项目类别:
A Novel Bone Targeted Antibiotic Therapy for the Treatment of Infected Fractures
一种治疗感染性骨折的新型骨靶向抗生素疗法
- 批准号:
10603486 - 财政年份:2023
- 资助金额:
$ 7.32万 - 项目类别:
Severe Cutaneous Adverse Reactions Following Outpatient Antibiotic Therapy: A Population-based Study
门诊抗生素治疗后的严重皮肤不良反应:一项基于人群的研究
- 批准号:
449379 - 财政年份:2020
- 资助金额:
$ 7.32万 - 项目类别:
Studentship Programs
Sex-Specific Differences in End-of-Life Burdensome Interventions and Antibiotic Therapy in Nursing Home Residents With Advanced Dementia
患有晚期痴呆症的疗养院居民的临终干预和抗生素治疗的性别差异
- 批准号:
422034 - 财政年份:2020
- 资助金额:
$ 7.32万 - 项目类别:
Optimizing outpatient parenteral antibiotic therapy to support hospital-in-the-home program across the unique environmental conditions of Australia
优化门诊肠外抗生素治疗,以支持澳大利亚独特环境条件下的家庭医院计划
- 批准号:
nhmrc : 1197866 - 财政年份:2020
- 资助金额:
$ 7.32万 - 项目类别:
Investigator Grants
Resistance evolution in the presence of combination antibiotic therapy
联合抗生素治疗下耐药性的演变
- 批准号:
2241853 - 财政年份:2019
- 资助金额:
$ 7.32万 - 项目类别:
Studentship
Host-pathogen interactions in antibiotic therapy for listeriosis
李斯特菌病抗生素治疗中宿主与病原体的相互作用
- 批准号:
18K07106 - 财政年份:2018
- 资助金额:
$ 7.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Multipurpose targeted nano-antibiotic therapy to fight tough infection in bones
多用途靶向纳米抗生素疗法可对抗骨骼中的严重感染
- 批准号:
9788269 - 财政年份:2018
- 资助金额:
$ 7.32万 - 项目类别:














{{item.name}}会员




